Remyelination therapy: How close are we?

Submitted by krupa.mistry on Thu, 11/02/2021 - 14:32

The damage caused to neurons during Multiple Sclerosis (MS) relapses makes the disease difficult to manage. Inflammatory stages of MS are treated using corticosteroids and disease modifying therapies (DMTs) (1). This relapsing remitting stage of MS also extends to the beginning stages of progressive MS which ultimately results in neurodegenerative symptoms caused by the deterioration of neurons (2,3).  

This is What a STEMinist Looks Like

Submitted by Beatrice on Thu, 11/02/2021 - 10:05

Half the UK population are unable to name one famous woman scientist, according to a report from education charity Teach First. How many can you name? Marie Curie and Ada Lovelace – that’s my lot. My teenage daughters weren’t much better: ‘Marie Curie and the woman who worked on DNA that no one remembers’ (Rosalind Franklin!).  

Our Office 2021 - No Place for Concrete Thinking

Submitted by Beatrice on Mon, 08/02/2021 - 11:11

The jury is still out on the world vision of office working once the pandemic restrictions subside. Twitter have announced that their employees can work from home ‘forever’, whereas the view from Netflix is that homeworking is ‘a pure negative’.1 

But, unlike AS&K, these big corporations have completely different considerations. We are being guided by listening to the needs of our staff.  

Mortality and Morbidity of COVID: Making the Most of the Situation

Submitted by Beatrice on Tue, 02/02/2021 - 08:53

On Christmas Day I received an email. It was addressed to my 7-year-old son, and it told him that his coronavirus test was positive. 

There were mixed emotions. I was amused at the thought of this strange Christmas present. I was also relieved – ever since his school had closed a day early the previous week because a teacher had tested positive we’d been living with uncertainty. Although a little scary, the knowledge we now had was reassuring. 

The Corpus scoops not one, but two awards!

Submitted by Beatrice on Tue, 26/01/2021 - 16:43

The Corpus had an incredibly busy year last year, with an unexpected increase in demand for online meeting solutions. We worked with pharmaceutical companies, speakers and healthcare professionals to deliver innovative and interactive online meetings that made a real difference, with 87% of attendees feeling more confident after the Corpus meetings, and a staggering 72% intending to make a change in their clinical practice as a result.

In December 2020, we were delighted to receive notification that Global Health & Pharma had bestowed two awards upon us: